Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4Teen4, Electrowire, Honeynaps, Merck, Novo Nordisk, Shionogi, Spinafx.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aspen, Axsome, Celcuity, Meridian, Orasis, Roche.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Apnimed, Autonomous Healthcare, Bioarctic, Biogen, Dexcom, Eisai, Hologic, Merck, Personalis, Sotio.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bavarian Nordic Biomarin, BMS, Claria, Clinuvel, Elevar, Enlivex, Eurofarma, Histosonics, Merck, Niagen, Oncolytics, Sydnexis, Tenpoint, Tolerogenixx, Universal, Zeta.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Forus, Leads Biolabs, Pharmaessentia, SL Science.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Absentia Labs, Leads Biolabs, Sanofi, SL Science, Swedish Orphan.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Arialys, Ihealth, Intas, Natera, Octapharma, Roche.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Grünenthal, Immunome, J&J, Merck, OS, Vanda, Vera.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Ascelia, Forus, Invivyd, Median, Pharmaessentia, Pharvaris, Visby.